Score Breakdown
Offering Ability
60
Cash Runway
65
Float Risk—
Warrant Exposure
15
Convertible Debt
40
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise
model 15%
• Under 12 months cash (9mo)
Market Data
Market CapN/A
Shares Outstanding16.10M
FloatN/A
Cash$3.41M
DebtN/A
Short InterestN/A
Institutional Holdings
Institutional data not yet available.
Short Interest
Short Interest962.5K
Days to Cover2.3
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
xbrl
XBRL CONVERTIBLE
2026-03-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual NMAD Dilution Snapshot
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (NMAD) has a DilutionScore of 58/100, rated High dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 113,310.
- Recent SEC activity tracked for NMAD: xbrl on 2026-06-30; xbrl on 2026-03-31.
- Score coverage note: Float Risk is excluded because public-float data is unavailable.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:
📖 Dilution Education
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.